Background: Pathogenesis of progressive liver fibrosis in biliary atresia after successful portoenterostomy remains unclear. We related hepatic expression of transforming growth factor beta (TGF-β) superfamily cytokines to histologic liver injury after successful portoenterostomy. Methods: Enrolled in our study were 28 patients with biliary atresia who had liver biopsies obtained during and after successful portoenterostomy, which normalized serum bilirubin ( < 20 μmol/l). Biopsies were evaluated for cholestasis, inflammation, ductal reaction, and fibrosis and were stained immunohistochemically for transforming growth factor beta 1, transforming growth factor beta 2, connective tissue growth factor, and decorin. Respective gene expression ( TGFB1, TGFB2, TGFB3, CTGF, DCN ) was analyzed at follow-up using quantitative reverse transcription polymerase chain reaction (qRT-PCR). Results were compared with fibrotic and healthy control livers. Results: After median follow-up of 3.0 years, histologic cholestasis resolved, whereas fibrosis had progressed only in isolated biliary atresia. Liver protein expression of transforming growth factor beta 1 and connective tissue growth factor ( P < .001 for both), but not that of transforming growth factor beta 2 or decorin, decreased after successful portoenterostomy, although expression of all four cytokines remained elevated. In accordance with postportoenterostomy changes in protein expression, follow-up ribonucleic acid expression of TGFB2 and DCN, but not that of TGFB1 and CTGF, was upregulated when compared with the controls. Both protein and gene expression of transforming growth factor beta 1 and protein expression of transforming growth factor beta 2, connective tissue growth factor and decorin correlated with METAVIR fibrosis stage. Syndromic patients ( n = 12) showed milder fibrosis and lower transforming growth factor beta 1 expression than patients with isolated biliary atresia. Conclusion: These findings support a central role of transforming growth factor beta superfamily in mediating continuing liver fibrogenesis after successful portoenterostomy. Transforming growth factor beta pathway cytokines responded divergently to clearance of jaundice, which was reflected by differential progression of fibrosis between syndromic and isolated patients.
Introduction
Biliary atresia (BA) is an obliterative fibroinflammatory cholangiopathy of infancy, with an incidence of 1 in 18,0 0 0-20,0 0 0 live births in Europe. [1] [2] [3] Genetic predisposition, developmental defects, The transforming growth factor beta (TGF-β) superfamily consists of several cytokines that play important roles in the regulation of hepatic fibrogenesis, growth, development, and immunity. [7] [8] [9] TGF-β is a potent activator of portal fibroblasts and hepatic stellate cells into α-smooth muscle acting ( α-SMA) expressing myofibroblasts, which mediate liver fibrogenesis by producing extracellular matrix proteins. 10, 11 Previous studies in BA have found an increased hepatic messenger ribonucleic acid (mRNA) and a protein expression of TGF-β at the time of diagnosis and in explants with advanced stages of the disease after development of liver failure. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Connective tissue growth factor (CTGF) synergizes the profibrotic actions of TGF-β, and its expression has been found to increase in BA. [23] [24] [25] Decorin is a proteoglycan involved in the maturation of collagen and possibly in attenuation of TGF-β1 activity in hepatic fibrogenesis. 26 We investigated how the expression of TGF-β superfamily members evolves and relates with histologic liver injury in BA patients after normalization of serum bilirubin by successful PE before development of clinical and biochemical signs of advanced liver dysfunction. This knowledge is essential for the development of novel management strategies to delay or prevent the progression of liver fibrosis after successful PE.
Materials and Methods

Patients and ethics
Of 51 BA patients operated in Helsinki University Hospital (Finland) between 1991 and 2013, 30 patients (59%) cleared their jaundice after PE, and 28 of them (93%) were enrolled. They underwent liver biopsy at PE. An ultrasound-guided core-needle liver biopsy was obtained during routine follow-up, including endoscopic variceal surveillance under anesthesia, abdominal ultrasound examination, and blood sampling. 27 Follow-up liver biopsies were part of the routine follow-up protocol not warranted by patients' clinical status. 28 Splenomegaly and portal hypertension were defined as described elsewhere. 27 Associated congenital anomalies were recorded from medical records and BA splenic malformation (BASM) was defined as having polysplenia or asplenia. 29 Study protocol was approved by 
Liver biopsies and immunohistochemistry
In total, 24 liver biopsies obtained at PE and 28 at followup were available for analyses. After fixation in formalin, embedding in paraffin, slicing, and staining, liver biopsies were analyzed semiquantitatively by two experienced pediatric pathologists for METAVIR fibrosis stage (0-4), portal inflammation (0-3), and intracanalicular cholestasis (0-3). 27 Immunohistologic studies were performed with antibodies for TGF-β1 (clone TGFB17; Leica Novocastra, Leica Biosystems, Nussloch, Germany), TGF-β2 (clone MGC116892; Abnova Corporation, Taipei City, Taiwan), CTGF (clone L-20; Santa Cruz Biotechnology Inc, Dallas, TX, USA), and decorin (clone NBP1-84970, Novus Biologicals, LLC, Littleton, CO, USA). Dilutions were 1:50, 1:10 0 0, 1:400, and 1:750, respectively. Blinded to clinical data, primary author (A.K.) performed semiquantitative immunohistologic gradings with a Leica DM RXA microscope (Leica Microsystems GmbH, Wetzlar, Germany), as follows:
• TGF-β1 and CTGF: 0 = negative, 1 = mild, 2 = moderate, and 3 = strong staining
• TGF-β2: 0 = negative, 1 = mild, and 2 = moderate staining
• decorin: 0 = slight expression at portal areas, 1 = expanded expression at portal areas, 2 = with portal-to-portal septaes, 3 = with portal-to-central septaes, 4 = expanded nodular expression (cirrhosis)
Staining of bile duct epithelial cells (BECs) was graded dichotomously for TGF-β2. The expression of TGF-β1 and CTGF were also evaluated for localization (most staining in fibrotic = 0, parenchymal = 1, or both areas = 2). The periportal staining pattern was graded dichotomously for TGF-β1, TGF-β2, and CTGF.
Cytokeratin-7 (CK-7) expression was used to visualize ductal reaction because it stains proliferating bile ductules, metaplastic hepatocyte-cholangiocyte intermediate cells, and bile ducts. 30, 31 Immunostaining for CK-7 was performed using SP52 monoclonal antibody and ultra View Universal DAB Detection KIT (Ventana, Tuscon, AZ, USA). Immunostaining for α-SMA, a marker of activated myofibroblasts, was performed as described in detail elsewhere. 32 The proportion of the antibody-positive area to the entire biopsy surface area (area fraction) was calculated for CK-7 and α- 
RNA expression analyses
RNA expression was analyzed from 24 BA patients with BA who had a liver RNA specimen available ( Table 1 ) . Liver tissue specimens were embedded in RNAlater-solution (Ambion, Life Technologies, Thermo Fischer Scientific Inc, Waltham, MA, USA) and frozen RNA was extracted with RNeasy Mini Kit (QIAGEN, Frederick, MD, USA). RNA integrity was determined spectrophotometrically, and the expression was analyzed in triplicate by quantitative real-time polymerase chain reaction using Human Fibrosis RT 2 Profiler PCR Array (QIAGEN SABiosciences, Frederick, MD, USA) on an ABI 7700 Sequence Detection System (Perkin-Elmer Lifer Sciences, Boston, MA, USA), according to the manufacturer's directions. Quantification of target gene mRNA expression was performed using the Ct method and expressed after normalization to housekeeping genes ( B2M, HPRT1, RPL13A, GAPDH, ACTB ) and relative to control subjects.
Analyses of serum TGF-β2 and decorin
The serum concentrations of TGF-β2 and decorin were determined using commercially available enzyme-linked immune sorbent assay (ELISA) kits by Biovendor R&D (Bratislava, Slovakia).
The analyses for human-TGF-β2 and human decorin were carried out according to the manufacturer's protocol. The interassay coefficient of variations (CV%) for TGF-β2 and decorin were 10.0% and 5.8 ng/mL, and detection limits were 6.6 and 56 pg/mL, respectively. Table 1 Hepatic gene expression of transforming growth factor-beta (TGF-β) superfamily in biliary atresia patients after a median follow-up of 3.0 years in relation to controls
Gene
Biliary atresia at follow-up Intestinal failure controls Cholelithiasis controls P value n = 24 n = 11 n = 10 
Results
Patient characteristics
Median patient (50% males) age at PE was 61 (interquartile range 40-84) days and 3.0 (2.1-6.7) years at follow-up. A total of 16 patients (57%) had isolated BA, and 12 patients (43%) had associated congenital anomalies (syndromic BA), including splenic malformations (BASM) in 8 patients (29%). At follow-up, splenomegaly was recorded in 9 patients (32%), and 14 patients (50%) had clinical signs of portal hypertension. After PE, bilirubin level had decreased from 159 (116-204) μmol/L to 10 (4-17) μmol/L, conjugated bilirubin from 115 (83-159) to 4 (2-8) μmol/L (both p < 0.001), and alanine aminotransferase from 87 (42-164) U/L to 45 (24-94) U/L, ( P = .012).
Evolution of histology and immunohistochemistry after PE
After successful PE, histologic liver fibrosis progressed in isolated BA patients, but remained unchanged in syndromic BA, and cholestasis disappeared and portal inflammation reduced in both groups ( Table 2 ) . CK-7 expression, which reflects the extension of ductal reaction, decreased significantly after PE in syndromic patients ( Table 2 ). The CK-7 area fraction correlated with METAVIR fibrosis stage both at PE (r = 0.611, P = .004) and at follow-up (r = 0.467, P = .014). METAVIR fibrosis stage was unrelated to follow-up age (r = 0.035, P = .859).
The hepatic expression of TGF-β1 and CTGF, but not that of TGF-β2 or decorin, significantly decreased after successful PE ( Table 2 , Figs 1 and 2 ) . However, the protein expression of all four Table 2 Histology and immunohistochemistry at portoenterostomy (PE) and after a median follow-up of 3.0 years 
TGF-β, transfroming growth factor-beta; CTGF , connective tissue growth factor. * Ductal reaction was analyzed using cytokeratin-7 immunostaining (area fraction). Note: Data are median (interquartile range). Significance was evaluated using Wilcoxon sign rank test.
cytokines remained significantly higher when compared with nonfibrotic control liver biopsies (0 [0-0], P < .003 for all, see Table   2 ). TGF-β1 was expressed around lobular hepatocytes and in fibrotic areas. The CTGF staining was perceived mainly as spindleshaped periportal cells, but especially at follow-up also in lobu- ( Table 2 and Fig 2 ) . Frequency of periportal TGF-β2 expression was significantly higher at follow-up (50%) than at PE (14%, P = .039; Fig 2 ) . At follow-up in 25% of samples, BECs expressed TGF-β2, which was not observed at PE (0%, P = .125). Expression of decorin was observed in portal and fibrotic areas similarly at PE and follow-up.
RNA expression of TGF-β-superfamily cytokines in BA patients compared with fibrotic and nonfibrotic controls
As presented in Table 1 , the follow-up RNA expression of TGFB2, TGFB3 , and DCN -but not that of TGFB1 and CTGF -was upregulated in BA patients compared with both control groups. Controls with intestinal failure had comparable liver METAVIR fibrosis stage (2 [2-2], P = .370) versus BA, and nonfibrotic controls were operated for cholelithiasis. The RNA expression of TGFBR1 and SMAD2 was also upregulated compared with both control groups. In contrast, the RNA expression of SMAD6 was significantly downregulated compared with nonfibrotic controls.
TGF-β1 expression correlated with liver fibrosis
In follow-up specimens both protein and RNA expression of TGF-β1 correlated positively with the METAVIR fibrosis stage ( Fig 3 ) . In addition, TGF-β2 ( Fig 3 ) , CTGF (r = 0.478, P = .012) and decorin (r = 0.825, P < .001) protein expression associated with fibrosis ( Fig 3 ) . At follow-up, the extension of CK-7 staining marking ductal reaction correlated with the decorin (r = 0.542, P = .006) and CTGF (r = 0.554, P = .003) expression. Table 3 presents relationships between α-SMA expression, denoting myofibroblast activation, and the expression of TGF-β 
Expression of TGF-β cytokines coupled with myofibroblast activation
Syndromic BA patients exhibited milder fibrosis and lower expression of TGF-β1 than isolated patients
As presented in Table 4 , histologic variables, age, and protein expression of TGF-β1 and 2, CTGF, and decorin were similar between syndromic and isolated BA patients at PE. In follow-up specimens obtained at a similar age, syndromic patients showed milder fibrosis and lower protein expression of TGF-β1 and decorin than isolated patients ( Tables 2 and 4 
Discussion
This is the first study to explore the evolution of hepatic TGF-β superfamily cytokine expression after successful PE and resolution of histologic and biochemical cholestasis. We found that the expression of TGF-β1 and CTGF-but not that of TGF-β2 or decorindecreased after successful PE. Both the RNA and protein expression of TGF-β1 correlated with the progression of fibrosis, which was more vigorous, along with a higher TGF-β1 expression, in isolated rather than in syndromic BA patients. These findings suggest that Table 3 Correlation of α-smooth muscle actin protein ( α-SMA area fraction) and gene The TGF-β superfamily forms one of the most potent driving forces for hepatic fibrogenesis through hepatic stellate cell activation and epithelial-to-mesenchymal transition. 7,9,26 Three major isoforms of TGF-β, TGF-β1, TGF-β2, and TGF-β3 show similar biologic effects in vitro, and their in vivo expression patterns are very dissimilar from one another. 8, 33 TGF-β1 is often described as the most abundant isoform in hepatic fibrosis. 8, 26, 34 We found that hepatic TFG-β1-but not TGF-β2-protein expression decreased after successful PE, and that TGF-β2 protein and RNA expression, together with TGF-β3 RNA expression, remained increased in follow-up specimens. Thus, TFG-β1 expression selectively decreased after a successful PE. In addition to a reduced TGF-β1 expression after a successful PE, both protein and RNA expression of TGF-β1correlated with a progression of histologic fibrosis in follow-up specimens, providing further support for involvement of TGF-β1 in the regulation of postoperative fibrogenesis. The most likely and obvious reason for downregulation of TFG-β1 expression after a successful PE is the resolution of cholestasis. 35 Interestingly, in syndromic patients the significant decrease in ductal reaction accompanied a lower TFG-β1 expression in relation to isolated patients. An alternative potential reason for the decreased TGF-β1 expression after PE may be a reduced TGF-β1-producing capacity when fibrosis progresses to cirrhosis and destroys TGF-β-storing cells. 7, 17, 19 did not correlate with histologic fibrosis. This may be explained by the fact that the majority of circulating TGF-β is in latent form. 9 Alterations in the TGF-β expression were accompanied with evocative changes in other superfamily members. The RNA expression of TGFBR1 encoding for TGF-β receptor 1 increased compensatorily, and SMAD2 promoting intracellular TGF-β signaling was upregulated. In contrast, the RNA expression of SMAD6 with an inhibitory effect on the TGF-β pathway was downregulated in BA patients compared with nonfibrotic controls. 8, 9, 33 Decorin has been reported to inhibit fibrogenesis by binding to TGF-β. 26 Accordingly, we found increased protein and gene expression of decorin after successful PE, suggesting that upregulation of a decorin expression may contribute to the deceleration of fibrosis after a successful PE by inhibiting TGF-β-driven fibrogenesis. Similar to TGF-β1, decorin expression is localized mainly in fibrotic areas and associated with the histologic fibrosis stage at PE and at follow-up. In our study, the protein expression of CTGF declined, the RNA expression remained unchanged, and the CTGF protein expression correlated with the fibrosis stage, paralleling the findings for TGF-β1. CTGF is produced by multiple mesenchymal and epithelial cell types and is recognized as a downstream mediator of TGF-β by synergizing its actions. 9, 23 In other studies, the hepatic CTGF expression has been found to be upregulated and to correlate with the degree of fibrosis at the time of PE. 20, 24, 25 In our earlier study, a molecular signature of active fibrogenesis persisted after a successful PE, whereas the RNA expression of various Th1 and Th2 proinflammatory cytokines was low, suggesting that inflammation may have a less central role in the progression of fibrosis after the clearance of jaundice. 32 In the present study, the coupling of TGF superfamily cytokines with the expression of α-SMA, a marker of extracellular matrix-producing myofibroblast, strengthens their role as active regulators of native liver fibrogenesis after the clearance of jaundice in BA.
Ductal reaction signifies a typical feature in cholangiopathies, where hepatocytes or progenitor cells transdifferentiate into CK-7 positive cell lineages and form immature biliary ductules. 30, 37 In BA, the extent of ductular reaction at PE correlates with fibrosis and a worse prognosis. 31 We found that the extension of ductular reaction decreased after PE only in syndromic patients and correlated with fibrosis and the expression of decorin and CTGF at follow-up.
This study had several limitations, such as a relatively small sample size and various sources of control material, because of the rare incidence of BA and obvious limited availability of control liver biopsies. In addition, protein or RNA expression of growth factors does not necessarily reflect their biological activity. 7, 26 However, this is one of the first studies to explore the TGF-β pathway in BA before the development of liver failure after a successful PE.
In conclusion, our findings support a central role of the TGF-β superfamily in driving liver fibrogenesis after a successful PE. The selective decline in TGF-β1 and CTGF expression and simultaneous upregulation of inhibitory decorin may contribute to unprogressive fibrogenesis after a successful PE, whereas the expression of TGF-β2 and TFG-β3 may have an opposite effect. Syndromic patients showed less progressive fibrosis, greater attenuation of ductal reaction, and a lower TGF-β1 expression than isolated ones, strengthening the possibility of different etiopathogenesis between these two subgroups. These findings may have important clinical implications for future development of antifibrogenic treatment strategies to delay or even prevent the need for LTx.
